Purchases and Sales Made in Q1 2024 in Bridge Bio Pharma, Inc. (BBIO)
This table provides information about the institutional ownership of Bridge Bio Pharma, Inc. (BBIO) during Q1 2024. The information is specifically focused on institutions that hold shares of BridgeBio Pharma, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-36.7K- 35.19% |
$1M - $1.49M
|
67.6K
$2.49M
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-41.8K- 40.33% |
$1.14M - $1.69M
|
61.9K
$2.28M
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-44K- 42.97% |
$1.2M - $1.78M
|
58.4K
$2.15M
|
|
May 15, 2024
Q1 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-59.9K- 16.56% |
$1.64M - $2.42M
|
302K
$11.1M
|
|
May 15, 2024
Q1 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-65.5K- 1.25% |
$1.79M - $2.65M
|
5.18M
$191M
|
|
May 13, 2024
Q1 2024
|
Healthcare Of Ontario Pension Plan Trust Fund
Toronto, A6 |
SELL
|
- |
-65.5K- 22.68% |
$1.79M - $2.65M
|
223K
$8.23M
|
|
May 08, 2024
Q1 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-75.2K- 6.69% |
$2.06M - $3.04M
|
1.05M
$38.6M
|
|
May 03, 2024
Q1 2024
|
Victory Capital Management Inc
|
SELL
|
- |
-111K- 24.2% |
$3.04M - $4.5M
|
348K
$12.8M
|
|
Apr 25, 2024
Q1 2024
|
Wcm Investment Management, LLC
Laguna Beach, CA |
SELL
|
- |
-118K- 40.36% |
$3.22M - $4.76M
|
174K
$6.41M
|
|
May 15, 2024
Q1 2024
|
Cormorant Asset Management, LP
Boston, MA |
SELL
|
- |
-141K- 4.22% |
$3.86M - $5.71M
|
3.2M
$118M
|
|
May 14, 2024
Q1 2024
|
Altitude Crest Partners Inc.
Stamford, CT |
SELL
|
- |
-143K- 18.89% |
$3.9M - $5.76M
|
612K
$22.6M
|
|
May 08, 2024
Q1 2024
|
Abrdn PLC
|
SELL
|
- |
-143K- 50.09% |
$3.9M - $5.77M
|
142K
$5.24M
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-191K- 40.39% |
$5.23M - $7.73M
|
282K
$10.4M
|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-222K- 22.98% |
$6.08M - $8.99M
|
745K
$27.4M
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-247K- 17.29% |
$6.76M - $10M
|
1.18M
$43.6M
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-274K- 21.52% |
$7.49M - $11.1M
|
999K
$36.8M
|
|
Oct 07, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-294K- 9.48% |
$8.03M - $11.9M
|
2.8M
$103M
|
|
May 09, 2024
Q1 2024
|
Lord, Abbett & Co. LLC
Jersey City, NJ |
SELL
|
- |
-294K- 9.48% |
$8.03M - $11.9M
|
2.8M
$103M
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-337K- 45.4% |
$9.21M - $13.6M
|
405K
$14.9M
|
|
May 15, 2024
Q1 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-337K- 19.26% |
$9.21M - $13.6M
|
1.41M
$52M
|
|
May 14, 2024
Q1 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-368K- 82.22% |
$10.1M - $14.9M
|
79.5K
$2.93M
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-478K- 28.79% |
$13.1M - $19.3M
|
1.18M
$43.6M
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-478K- 28.79% |
$13.1M - $19.3M
|
1.18M
$43.6M
|
|
May 15, 2024
Q1 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-507K- 54.82% |
$13.9M - $20.5M
|
418K
$15.4M
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-849K- 69.85% |
$23.2M - $34.4M
|
367K
$13.5M
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.64M- 50.23% |
$44.9M - $66.4M
|
1.63M
$59.9M
|